A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Investigator: Bincy Abraham, MD

Study Coordinator: Mayyadah Al-Sabbagh

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT01848561

Phone: 346.238.0307

Protocol Number: Pro00011106


This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.
More to Explore